Employee Benefit News July 15, 2025
The demand for weight loss drugs has skyrocketed over the past several years, but GLP1-s alone won’t lead to long-term, holistic health changes for employees.
GLP-1 use for overweight and obesity conditions has increased 587% over the past five years, according to a study by FAIR Health, and data from the International Foundation of Employee Benefit Plans shows the drugs now account for 10.5% of total annual employer claims.
But their success rate is complicated. Research shows that issues such as cost, side effects, weight plateau and lack of effectiveness cause around half of users to discontinue the medication after a year, underlining that, on their own, GLP-1s are not a long-term weight loss solution.
“Most patients...
Today's Sponsors
Today's Sponsor